Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,637 | 3,593 | 0 | N/A | N/A |
| Receivables | 7,832 | 15,130 | 0 | N/A | N/A |
| Inventories | 20,322 | 17,625 | 0 | N/A | N/A |
| TOTAL | $35,134 | $41,551 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,179 | 3,202 | 0 | N/A | N/A |
| Intangibles | 46,654 | 25,118 | 0 | 0 | 0 |
| Other Non-Current Assets | 41,800 | 50,100 | 0 | 0 | 0 |
| TOTAL | $92,633 | $78,420 | $N/A | $N/A | $N/A |
| Total Assets | $127,767 | $119,971 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,084 | 11,472 | 0 | 0 | 0 |
| Accrued Expenses | 3,334 | 4,118 | 0 | N/A | N/A |
| Other current liabilities | 2,682 | 3,365 | 0 | N/A | N/A |
| TOTAL | $19,943 | $19,835 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,843 | 880 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 71 | 0 | 0 | 0 | 0 |
| TOTAL | $19,206 | $5,528 | $N/A | $N/A | $N/A |
| Total Liabilities | $39,149 | $25,363 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -231,988 | -172,671 | 0 | N/A | N/A |
| Other shareholders' equity | 320,606 | 267,279 | 0 | 0 | 0 |
| TOTAL | $88,618 | $94,608 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $127,767 | $119,971 | $0 | $0 | $0 |